pharma
AstraZeneca’s Calquence shows strength in most common adult leukaemia
June 6, 2019Research and Development AstraZeneca, Calquence, chronic lymphocytic leukaemia, pharma
AstraZeneca has unveiled new Phase 3 data for Calquence (acalabrutinib) in treatment-naïve chronic lymphocytic leukaemia, showing that the drug met …
Donald Trump causes confusion as to whether NHS will be ‘on the table’ in trade deal talks
June 6, 2019Business Services, Medical Communications Donald Trump, NHS, UK, US, healthcare, pharma
President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit …
FDA approves new indication for MSD’s Zerbaxa
June 5, 2019Research and Development Merck, Zerbaxa, bacterial infection, pharma
The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial …
AbbVie’s Venclyxto combo outclasses chemo in treatment-naive chronic lymphocytic leukaemia
June 5, 2019Research and Development ASCO 2019, AbbVie, Venclyxto, pharma
AbbVie was one of many companies to present new data at this year’s American Society of Clinical Oncology (ASCO) Annual …
Eli Lilly’s Emgality approved in the US for episodic cluster headache
June 5, 2019Research and Development, Sales and Marketing Eli Lilly, Emgality, episodic cluster headache, migraine, pharma
Eli Lilly’s Emgality (galcanezumab-gnlm) self-administered injection solution has secured approval in the US for the treatment of episodic cluster headache, …
Former FDA Commissioner returns to venture capital firm
June 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma
Dr Scott Gottlieb, former Commissioner for the FDA, has returned to his venture capital background with the announcement that he …
Darzalex combo makes strong Phase 3 showing in multiple myeloma
June 4, 2019Manufacturing and Production, Research and Development ASCO 2019, Cancer, Janssen, darzalex, multiple myeloma, pharma
Janssen joined its contemporaries at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago in the release …
Janssen’s Imbruvica shows superiority in Phase 3 trials
June 4, 2019Manufacturing and Production Janssen, imbruvia, leukaemia, pharma, phase 3, trial
Phase 3 data from ASCO 2019 has shown Janssen’s leukaemia drug Imbruvica (ibrutinib) had significant benefits over ofatumumab. In the …
EMA approves Bluebird Bio’s gene therapy Zynteglo
June 4, 2019Manufacturing and Production Bluebird Bio, European comission, gene therapy, health, pharma
The European Commission has granted a conditional marketing authorisation to bluebird bio’s gene therapy Zynteglo. The Massachusetts-based firm’s one time …
Walmart join MediLedger medical supply chain blockchain network
June 3, 2019Manufacturing and Production MediLedger, blockchain, medical supply chain, pharma
Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the …
Working Life: Monika Pocinkova, Vice President, HR Speciality Care, Ipsen UK & Ireland
June 3, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, pharma
Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …
Isatuximab improves on standard of care treatments for multiple myeloma
June 3, 2019Sales and Marketing Cancer, Immunogen, Sanofi, isatuximab, multiple myeloma, pharma
Sanofi and ImmunoGen’s isatuximab combination therapy prolonged progression free survival by five months compared to standard of care treatments in …
Novartis’ Kisqali combo boosts survival in HR+/HER2- advanced breast cancer
June 3, 2019Research and Development, Sales and Marketing Cancer, Kisqali, Novartis, breast cancer, pharma
Novartis took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to reveal new Phase 3 …
Dr Dietmar Berger returns to big pharma
May 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atara, R&D, Sanofi, oncology, pharma, research
Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …
Biogen’s diroximel fumarate impresses at Phase 3 in relapsing multiple sclerosis
May 31, 2019Medical Communications, Research and Development Biogen, diroximel fumarate, multiple sclerosis, pharma, relapsingg multiple sclerosis
New data for Biogen’s investigational therapy diroximel fumarate has been revealed at the Consortium of Multiple Sclerosis Centers (CMSC) in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
